WO2002003791A8 - Souris transgeniques contenant des interruptions de genes - Google Patents

Souris transgeniques contenant des interruptions de genes

Info

Publication number
WO2002003791A8
WO2002003791A8 PCT/US2001/021822 US0121822W WO0203791A8 WO 2002003791 A8 WO2002003791 A8 WO 2002003791A8 US 0121822 W US0121822 W US 0121822W WO 0203791 A8 WO0203791 A8 WO 0203791A8
Authority
WO
WIPO (PCT)
Prior art keywords
transgenic mice
targeted gene
mice containing
gene disruptions
containing targeted
Prior art date
Application number
PCT/US2001/021822
Other languages
English (en)
Other versions
WO2002003791A2 (fr
WO2002003791A3 (fr
Inventor
Michael W Leviten
Keith D Allen
Original Assignee
Deltagen Inc
Michael W Leviten
Keith D Allen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deltagen Inc, Michael W Leviten, Keith D Allen filed Critical Deltagen Inc
Priority to AU2001273351A priority Critical patent/AU2001273351A1/en
Publication of WO2002003791A2 publication Critical patent/WO2002003791A2/fr
Publication of WO2002003791A8 publication Critical patent/WO2002003791A8/fr
Publication of WO2002003791A3 publication Critical patent/WO2002003791A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des animaux transgéniques ainsi que des compositions et des méthodes se rapportant à la caractérisation de la fonction génique. D'une manière plus spécifique, l'invention concerne des souris transgéniques présentant des mutations de gène cible. Lesdites souris transgéniques sont utiles comme modèles pour des maladies et permettent d'identifier des agents qui modulent l'expression et la fonction géniques. En outre, l'invention concerne des traitements potentiels de diverses maladies et états pathologiques.
PCT/US2001/021822 2000-07-10 2001-07-10 Souris transgeniques contenant des interruptions de genes WO2002003791A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001273351A AU2001273351A1 (en) 2000-07-10 2001-07-10 Transgenic mice containing targeted gene disruptions

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US21745000P 2000-07-10 2000-07-10
US60/217,459 2000-07-10
US21732600P 2000-07-11 2000-07-11
US21735000P 2000-07-11 2000-07-11
US60/217,350 2000-07-11
US60/217,326 2000-07-11
US22316900P 2000-08-07 2000-08-07
US22311900P 2000-08-07 2000-08-07
US60/223,169 2000-08-07
US60/223,119 2000-08-07
US26604801P 2001-02-01 2001-02-01
US26604501P 2001-02-01 2001-02-01
US60/266,048 2001-02-01
US60/266,045 2001-02-01
US30121401P 2001-06-26 2001-06-26
US60/301,214 2001-06-26

Publications (3)

Publication Number Publication Date
WO2002003791A2 WO2002003791A2 (fr) 2002-01-17
WO2002003791A8 true WO2002003791A8 (fr) 2003-02-20
WO2002003791A3 WO2002003791A3 (fr) 2003-07-10

Family

ID=27575196

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021822 WO2002003791A2 (fr) 2000-07-10 2001-07-10 Souris transgeniques contenant des interruptions de genes

Country Status (1)

Country Link
WO (1) WO2002003791A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698766A (en) * 1995-04-05 1997-12-16 The Regents Of The University Of California Transgenic animal model for testing drugs for treating eating disorders and epilepsy
AU4384797A (en) * 1996-09-13 1998-04-02 Novartis Ag Neurological disease model
WO2000036910A1 (fr) * 1998-12-22 2000-06-29 Albert Einstein College Of Medicine Souris dont le gene msh5 a ete modifie et utilisations de ces dernieres

Also Published As

Publication number Publication date
WO2002003791A2 (fr) 2002-01-17
WO2002003791A3 (fr) 2003-07-10

Similar Documents

Publication Publication Date Title
WO2002079440A3 (fr) Souris transgeniques contenant des ruptures du gene gpcr5-1
WO2002079424A3 (fr) SOURIS TRANSGENIQUES CONTENANT DES DISRUPTIONS DE GENES Gβ3GALT2
WO2002046390A3 (fr) Souris transgeniques a disruptions geniques de tyrosine phosphatase rptpb
WO2002079438A3 (fr) Disruptions du gene ogr1, compositions et procedes associes
WO2003026395A3 (fr) Disruptions geniques mo54, compositions et procedes correspondants
WO2002003789A3 (fr) Souris transgéniques contenant des disruptions géniques gpcr ciblées
WO2002040662A3 (fr) Souris transgenique contenant des disruptions geniques ciblees
WO2001067855A3 (fr) Souris transgeniques contenant des interruptions de genes ciblees
WO2002048345A3 (fr) Souris transgeniques presentant des disruptions geniques du recepteur de glutamate (grik5)
WO2002045498A3 (fr) Souris transgenique presentant des disruptions geniques ciblees de proteine canal
WO2002001950A3 (fr) Souris transgeniques contenant des interruptions de genes cibles
WO2002081658A8 (fr) Souris transgeniques comportant des disruptions geniques sur le canal des ions calcium cacnb4
WO2002048342A3 (fr) Souris transgeniques presentant des interruptions du gene trp6 au niveau du canal ion calcium
WO2002003788A3 (fr) Souris transgeniques contenant des disruptions ciblees du gene de la phosphatase
WO2002003793A3 (fr) Souris transgeniques contenant des disruptions genetiques ciblees
WO2002037957A3 (fr) Souris transgeniques contenant des disruptions geniques de la proteine kinase de perk
WO2002079414A8 (fr) Souris transgeniques contenant des ruptures du gene des canaux de chlorure clcn7
WO2002003787A3 (fr) Souris transgéniques contenant des disruptions géniques ciblées
WO2003026403A3 (fr) Disruptions du gene ctsz, compositions et methodes correspondantes
WO2002079433A3 (fr) Souris transgeniques presentant des disruptions du gene tmem3 de la beta-1,3-n-acetylglucosaminyltransferase
WO2002003791A3 (fr) Souris transgeniques contenant des interruptions de genes
WO2002079412A3 (fr) Souris transgenique presentant des disruption geniques dues a la presence d'une enzyme de desubiquitination de type usp3
WO2002055687A3 (fr) Souris transgeniques presentant des disruptions geniques cibles
WO2002048346A3 (fr) Souris transgeniques contenant des disruptions geniques d'une proteine a ancrage membranaire specifique du cerveau
WO2002046391A3 (fr) Souris transgeniques contenant des interruptions de gene nor1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 03/2002 UNDER (63) REPLACE "US, 60/223160 (CON)" BY "US, 60/223169 (CON)" AND REPLACE "US, NOT FURNISHED (CON) FILED ON 20010628" BY "US, 60/301214 (CON) FILED ON 20010626"

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP